106569238The transition is orderly with no gap in compliance coverage — Pandey exits on 29 March and Patel assumes charge on 1 April 2026. Patel is an Associate Member of ICSI with 3 years of experience in listed and group company compliances. The resignation was tendered as early as 2 January 2026, suggesting the Board had ample time to arrange a successor.
For a small-cap company (₹47 Cr market cap), continuity of the Compliance Officer role is operationally significant given regulatory obligations under SEBI LODR. The seamless handover reduces the risk of compliance lapses. Investor impact is minimal as this is a routine personnel change with no strategic or financial implications.
High impact event - Company Name: Mangalam Drugs and Organics Limited - Event: Resignation of Company Secretary Ms. Anuradha Pandey (effective 29 March 2026) and appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer (effective 1 April 2026) - Time: March 26, 2026 (Board meeting: 12:00 PM – 12:40 PM) Key Insight: The transition is orderly with no gap in compliance coverage — Pandey exits on 29 March and Patel assumes charge on 1 April 2026. Patel is an Associate Member of ICSI with 3 years of experience in listed and group company compliances. The resignation was tendered as early as 2 January 2026, suggesting the Board had ample time to arrange a successor. Why it matters: For a small-cap company (₹47 Cr market cap), continuity of the Compliance Officer role is operationally significant given regulatory obligations under SEBI LODR. The seamless handover reduces the risk of compliance lapses. Investor impact is minimal as this is a routine personnel change with no strategic or financial implications. Market cap: ₹47.17 Cr sector: Pharmaceuticals & Specialty Chemicals confidence score: 3 Source: NSE Corporate Announcement Link: https://www.nseindia.com/companies-listing/corporate-filings-announcements